Zosano Pharma (ZSAN) Stock: Rocketing On Study Milestone Completion

Zosano Pharma ZSAN Stock News

Zosano Pharma Corp (NASDAQ: ZSAN) is flying in the pre-market hours this morning, and for good reason. The company announced that it has completed a key clinical milestone, exciting investors and sending the stock running for the top. Today, we’ll talk about: The milestone; what we’re seeing from ZSAN stock as a result; and what … Read more

Immune Design (IMDZ) Stock: Gaining In Multiples On Acquisition News

Immune Design IMDZ Stock News

Immune Design Corp (NASDAQ: IMDZ) is having an incredibly strong start to the trading session this morning, gaining in multiples after announcing acquisition news. Of course, the acquisition excited investors, pushing the stock on a run for the top. Today, we’ll talk about: The acquisition; what we’re seeing from IMDZ stock as a result; and … Read more

Trovagene (TROV) Stock: Providing New Cancer Treatment Options With Onvansertib

Trovagene TROV Stock News

We all know what cancer is. The debilitating, often life-threatening condition can be incredibly difficult to treat. As a result, new therapies are being developed in an effort to bring improved treatment options to patients, especially for some of the toughest-to-treat cancers. That’s where Trovagene (Nasdaq: TROV) comes in with their drug candidate, Onvansertib. Trovagene caught … Read more

Arca Biopharma (ABIO) Stock: Screaming For The Top On FDA News

Arca Biopharma ABIO Stock News

Arca Biopharma Inc (NASDAQ: ABIO) is having an incredibly strong start to the trading session, gaining in multiples in the pre-market. The gains come after the company announced news from the FDA. Of course, the news was positive, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The FDA news; … Read more

Med-X: Are You Paying Attention Yet

Med-X investing news

Med-X is a company that I’ve discussed in great detail in the past, and for good reason. I believe that the company represents a strong opportunity across multiple sectors. While the company is focused in multiple areas of business, the pesticides business is the one that, to me, is worth the most attention. That’s because … Read more

Pernix Therapeutics (PTX) Stock: Falling Apart On Bankruptcy And Takeover News

Pernix Therapeutics PTX Stock News

Pernix Therapeutics Holdings Inc (NASDAQ: PTX) is having a horrible day in the market today, and for good reason. The company announced that it has entered into an asset purchase agreement and filed Chapter 11 bankruptcy. Unfortunately, the news upset investors, sending the stock tumbling down. Today, we’ll talk about: The bankruptcy; what we’re seeing … Read more